FGF7 Gene - Fibroblast Growth Factor 7

Key regulator of epithelial cell growth and wound healing

Gene Information Card

Symbol FGF7
Full Name Fibroblast Growth Factor 7
Gene Type Protein coding
Chromosomal Location 15q21.1
NCBI Gene ID 2252 ncbi.nlm.nih.gov/gene/2252
Ensembl ID ENSG00000140285
UniProt ID P21781
OMIM ID 148180
HGNC ID 3685
Aliases KGF, HBGF-7

Description

FGF7 (fibroblast growth factor 7), also known as keratinocyte growth factor (KGF), is a member of the fibroblast growth factor family. It is primarily expressed by mesenchymal cells and acts specifically on epithelial cells via the FGFR2b receptor. FGF7 plays a critical role in embryonic development, epithelial cell proliferation, differentiation, and wound healing. Dysregulation of FGF7 is implicated in various cancers and inflammatory conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (e.g., breast, prostate, lung) Overexpression of FGF7 promotes epithelial-mesenchymal transition (EMT) and tumor growth via autocrine/paracrine signaling through FGFR2b. Multiple studies in COSMIC and PubMed; elevated FGF7 expression correlates with poor prognosis.
Chronic wounds / impaired healing Reduced FGF7 expression in diabetic ulcers leads to defective keratinocyte proliferation and delayed re-epithelialization. Clinical evidence from wound healing studies; FGF7 treatment improves healing in animal models.
Inflammatory bowel disease (IBD) Altered FGF7 levels in intestinal mucosa contribute to epithelial barrier dysfunction and inflammation. Gene expression profiling in IBD patients shows dysregulated FGF7.

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 12.5 Medium
Lung 8.3 Low
Kidney 6.1 Low
Prostate 4.7 Low
Breast 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HaCaT (keratinocytes) 15.0 High expression; used as model for epithelial response
MCF7 (breast cancer) 2.1 Low expression; exogenous FGF7 stimulates proliferation
A549 (lung cancer) 1.8 Low endogenous expression; paracrine source from fibroblasts
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Likely loss of function; reported in ClinVar
c.364C>T (p.Arg122Trp) Missense Unknown Potential gain of function; observed in COSMIC for colorectal cancer
Mutation functional classification

Loss of Function (LOF)

Rare missense variants (e.g., p.Met1?) that disrupt protein synthesis or secretion, leading to impaired epithelial growth.

Gain of Function (GOF)

Mutations that enhance FGF7 stability or receptor binding, promoting oncogenic signaling (e.g., p.Arg122Trp).

Dominant Negative (DN)

Not well documented for FGF7; no confirmed dominant-negative mutations reported.

Pathways

FGF signaling pathway (KEGG: hsa04010)
MAPK signaling pathway (KEGG: hsa04010)
PI3K-Akt signaling pathway (KEGG: hsa04151)
Regulation of epithelial-mesenchymal transition

Protein Summary

FGF7 is a 194-amino acid secreted protein (UniProt P21781) that belongs to the fibroblast growth factor family. It contains a conserved FGF domain and binds specifically to the FGFR2b splice variant. The protein is synthesized as a precursor with a signal peptide (residues 1-31) and is processed to the mature form (residues 32-194). FGF7 is heat-labile and heparin-binding, stabilizing its interaction with the receptor. It stimulates proliferation, migration, and differentiation of epithelial cells, playing a key role in tissue repair and development.

Related Products

Product name Cat.No. Species Gene ID
FGF7 Knockout HEK293 Cell Line EDJ-KQ1195 Human 2252 Details Get a Quote
FGF7 Knockout HeLa Cell Line EDJ-KQ53225 Human 2252 Details Get a Quote
FGF7 Knockout A-549 Cell Line EDJ-KQ61703 Human 2252 Details Get a Quote
FGF7 Knockout HCT 116 Cell Line EDJ-KQ70191 Human 2252 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: